12 Health Care Stocks Moving In Thursday's After-Market Session
$ACOR
$ADXN
$BVXV
$ENVB
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Biotechnology: Pharmaceutical Preparations
Health Care
Gainers
- First Wave BioPharma (NASDAQ:FWBI) shares moved upwards by 20.7% to $1.75 during Thursday's after-market session. First Wave BioPharma's trading volume hit 64.7K shares by close, accounting for 7.7% of its average volume over the last 100 days. The market value of their outstanding shares is at $2.4 million.
- NanoVibronix (NASDAQ:NAOV) stock moved upwards by 11.74% to $0.51. The company's market cap stands at $14.2 million.
- Enveric Biosciences (NASDAQ:ENVB) shares increased by 11.36% to $4.8. The company's market cap stands at $9.9 million.
- OpGen (NASDAQ:OPGN) stock increased by 8.17% to $0.41. The market value of their outstanding shares is at $19.6 million.
- Soleno Therapeutics (NASDAQ:SLNO) shares rose 7.36% to $1.75. The market value of their outstanding shares is at $14.1 million.
- Acorda Therapeutics (NASDAQ:ACOR) stock increased by 7.01% to $0.3. The company's market cap stands at $7.2 million.
Losers
- Histogen (NASDAQ:HSTO) shares declined by 14.1% to $1.22 during Thursday's after-market session. The market value of their outstanding shares is at $3.0 million.
- Addex Therapeutics (NASDAQ:ADXN) stock declined by 12.49% to $0.7. The company's market cap stands at $5.7 million.
- Windtree Therapeutics (NASDAQ:WINT) shares fell 10.03% to $0.31. Today's trading volume for this security ended up closing at 10.0 million shares, which is 687.5 percent of its average volume over the last 100 days. The company's market cap stands at $9.3 million.
- TC BioPharm (Holdings) (NASDAQ:TCBP) stock fell 9.68% to $0.25. The company's market cap stands at $7.1 million.
- BiondVax Pharmaceuticals (NASDAQ:BVXV) shares fell 7.71% to $0.6. The company's market cap stands at $11.2 million.
- MSP Recovery (NASDAQ:MSPR) stock decreased by 7.26% to $1.15. The market value of their outstanding shares is at $76.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.